• Kiniksa Pharmaceuticals International Chief Accounting Officer Michael R. Megna sold 11,280 Class A Ordinary Shares at $98.54 on Nov. 9, 2026.
• Megna also exercised options for 11,280 Class A Ordinary Shares at $17.76 each on the same date.
• Following the transactions, he directly owned 12,697 Class A Ordinary Shares and held 5,114 share options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001464583-26-000012), on November 12, 2026, and is solely responsible for the information contained therein.